Feb 13 (Reuters) - Quidel Corp:
* QUIDEL RECEIVES 510(K) CLEARANCE FOR QUICKVUE INFLUENZA A+B TEST, ASSAY MEETS FDA’S CLASS II RIDT REQUIREMENTS
* QUIDEL- IN RECENT CLINICAL STUDY, CO’S QUICKVUE INFLUENZA A+B TEST SHOWN TO MEET FDA RECLASSIFICATION CRITERIA FOR CLASS II RAPID INFLUENZA DIAGNOSTIC TESTS Source text for Eikon: Further company coverage: